PTCT · Categories · Coverage
PTCT - Analyst coverage initiated
PTC Therapeutics Inc. (PTCT) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for PTCT
- Raymond James initiated coverage on PTC Therapeutics with a new price targetRaymond James initiated coverage of PTC Therapeutics with a rating of Outperform and set a new price target of $108.00
- Wells Fargo initiated coverage on PTC Therapeutics with a new price targetWells Fargo initiated coverage of PTC Therapeutics with a rating of Overweight and set a new price target of $73.00
- Truist initiated coverage on PTC Therapeutics with a new price targetTruist initiated coverage of PTC Therapeutics with a rating of Buy and set a new price target of $80.00
- Scotiabank initiated coverage on PTC Therapeutics with a new price targetScotiabank initiated coverage of PTC Therapeutics with a rating of Sector Perform and set a new price target of $55.00
- Robert W. Baird initiated coverage on PTC Therapeutics with a new price targetRobert W. Baird initiated coverage of PTC Therapeutics with a rating of Outperform and set a new price target of $44.00
- Wells Fargo initiated coverage on PTC Therapeutics with a new price targetWells Fargo initiated coverage of PTC Therapeutics with a rating of Overweight and set a new price target of $37.00
- SVB Securities initiated coverage on PTC Therapeutics with a new price targetSVB Securities initiated coverage of PTC Therapeutics with a rating of Market Perform and set a new price target of $48.00
- Goldman initiated coverage on PTC Therapeutics with a new price targetGoldman initiated coverage of PTC Therapeutics with a rating of Sell and set a new price target of $35.00
- Jefferies initiated coverage on PTC Therapeutics with a new price targetJefferies initiated coverage of PTC Therapeutics with a rating of Buy and set a new price target of $62.00
- Morgan Stanley initiated coverage on PTC Therapeutics with a new price targetMorgan Stanley initiated coverage of PTC Therapeutics with a rating of Equal-Weight and set a new price target of $54.00
- Citigroup initiated coverage on PTC Therapeutics with a new price targetCitigroup initiated coverage of PTC Therapeutics with a rating of Buy and set a new price target of $70.00